FDA authorizes Pfizer’s COVID-19 booster for children aged 5 to 11 years

The FDA on Tuesday authorized a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11 years.
The amended emergency use authorization means children can receive a booster dose of the vaccine at least 5 months after they complete the primary series.
Part of the reason for the authorization was the omicron wave, FDA Commissioner Robert M. Califf, MD, said.
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may

The FDA on Tuesday authorized a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11 years.
The amended emergency use authorization means children can receive a booster dose of the vaccine at least 5 months after they complete the primary series.
Part of the reason for the authorization was the omicron wave, FDA Commissioner Robert M. Califf, MD, said.
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may